We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MGRX:NASDAQMangoceuticals, Inc. analysis

Data as of Sep 27, 2026 - not real-time

Latest price
$0.47
Risk: high
9/10High risk

Summary

At $0.4660, Mangoceuticals, Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has lost 12.6% over the past 30 days. RSI sits at 55.6, which reads as neutral, and MACD momentum is bullish. Price has been bracketed by support at $0.3730 and resistance at $0.4800.
Revenue is contracting at 59.1%.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 87.8%, a beta of 1.26 and a maximum drawdown of 94.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Market outlook

Short term

< 1 year

Neutral

Model confidence2/102 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 0.48
  • MACD momentum is positive

Medium term

1–3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 0.48
  • 30-day volatility of 87.8%

Long term

> 3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • Negative return on equity of -95.1%
  • Revenue contracting at -59.1%
  • 30-day volatility of 87.8%

Key metrics

Financial health

Revenue Growth-59.10%
ROE-95.10%
ROA-46.97%
Debt/Equity2.23
P/B Ratio0.7
Op. Cash Flow$-3890874
Free Cash Flow$1.3M
Industry P/E30.5

Technical analysis

TrendBearish
RSI55.6
Support$0.37
Resistance$0.48
MA 20$0.42
MA 50$0.46
MA 200$0.48
MACDBullish
VolumeIncreasing
Fear & Greed Index94.88

Valuation

Fair Value$0.70
GradeFair
TypeBlend

Risk assessment

Beta1.26
Volatility87.85%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.